Firefly Neuroscience Inc (AIFF)
Firefly Neuroscience, Inc. is a healthcare technology company focused on medical technology and artificial intelligence applications for brain health. Through its Brain Network Analytics software, the company supports diagnostic and treatment-related use cases in areas such as depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Its solutions are intended for use by pharmaceutical companies and medical practitioners. Firefly Neuroscience was founded in 2006 and is headquartered in Kenmore, New York. The company’s common stock trades on the NASDAQ under the symbol AIFF.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AIFF
|
$1.34
|
6.2% Upside
|
Fair
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 13, 2026
|
1.3x
|
11.0x
|
19.77 M
|
10.544 M
|
0.0%
|
89.4%
|
-10.0
|
76.3%
|
